CIVA

A prestigious award that provides protected time of 0.2 FTE for 2 years for experienced CIVs to further develop their research focus. The CIVA programme supports awardees in their journey to become recognised as independent established clinician researchers of international standing, supported by various grants, leading / co-leading research platforms, and contributing as active collaborators and academic clinician leaders in the AMC, ultimately translating research findings.

Applications have closed on 4 March 2022. The next cycle opens in FY2023.

Please submit your applications through your respective ACP.

Eligibility & Evaluation Criteria

Each submission must be made using the prescribed forms:

CIV Advancement Programme Application Form (to be completed by applicant)
Applicant CV & Career Development Plan (to be completed by applicant)
Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable)).

Failure to comply with the requirements and/or an incomplete application will result in disqualification from review.

For applicants who are planning to apply for national level funding, are already holding national grants, or are supported by clinical trials etc., justification is required for the need of protected time in your application for the Clinician Investigator Advancement Programme.

For shortlisted applicants, a short interview with the review panel may be required. Details concerning the interview will be disseminated once it is finalised.

For successful applicants, the outcomes of the research programme / platform will be monitored during and after the award tenure. Applicants are expected to submit these periodically during and after the tenure of the award.